EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin‐Sensitive Magnetic Resonance Imaging and 18 F‐Fluorodopa‐Positron Emission Tomography

Paula Trujillo iD, Kaitlyn R O'Rourke, Olivia C Roman, Alexander K Song, Kilian Hett, Amy Cooper, Bonnie K Black, Manus J Donahue, Cyndya A Shibao, Italo Biaggioni, Daniel O Claassen

Movement Disorders · 2025

DOI: 10.1002/mds.30119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Paula Trujillo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Magnetic Resonance Imaging, Melanins, Pure Autonomic Failure. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Central synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), involve alpha‐synuclein accumulation and dopaminergic cell loss in the substantia nigra (SN) and locus coeruleus (LC). Pure autonomic failure (PAF), a peripheral synucleinopathy, often precedes central synucleinopathies.

Objectives

To assess early brain involvement in PAF using neuromelanin‐sensitive magnetic resonance imaging (NM‐MRI) and fluorodopa‐positron emission tomography (FDOPA‐PET), and to determine whether PAF patients with a high likelihood ratio (LR) for conversion to a central synucleinopathy exhibit reduced NM‐MRI contrast in the LC and SN compared with controls and low‐LR patients.

Methods

Participants with PAF ( n = 23) were categorized as high‐LR ( n = 13) or low‐LR ( n = 10) for conversion to central synucleinopathy. Additional participants included PD ( n = 22), DLB ( n = 8), and age‐ and sex‐matched healthy controls ( n = 23). NM‐MRI at 3 T was used to quantify contrast ratios in the LC and SN, while FDOPA‐PET measured presynaptic dopamine synthesis. Linear regression analyses, adjusted for age and sex, were used to compare NM‐MRI contrast across groups.

Results

High‐LR PAF patients showed reduced contrast in the LC and SN compared with controls and low‐LR PAF patients, with values similar to PD and DLB. The NM‐MRI contrast in the SN correlated with dopamine uptake in the striatum. Longitudinal imaging in PAF patients ( n = 6) demonstrated reduced NM‐MRI and PET values in individuals who developed central synucleinopathies.

Conclusions

NM‐MRI and FDOPA‐PET may serve as potential biomarkers for early brain involvement and predicting progression to central synucleinopathies in PAF and could help identify patients for early intervention. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyMagnetic Resonance ImagingMelaninsPure Autonomic FailureSynucleinopathiesHumansMaleFemaleAgedMiddle AgedDihydroxyphenylalanineParkinson DiseaseLewy Body DiseaseMultiple System AtrophyLocus CoeruleusSubstantia NigraAged, 80 and over

Stichwörter der Autor:innen

FDOPAMRIneuromelaninphenoconversionpure autonomic failuresynucleinopathies

Substanzen

MelaninsneuromelaninDihydroxyphenylalaninefluorodopa F 18

Autor:innen und Institutionen

  • Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Paula Trujillo

Förderung

  • NINDS NIH HHS
  • NIA NIH HHS
  • NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Trujillo, P., O'Rourke, K. R., Roman, O. C., Song, A. K., Hett, K., Cooper, A., Black, B. K., Donahue, M. J., Shibao, C. A., Biaggioni, I., & Claassen, D. O. (2025). Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin‐Sensitive Magnetic Resonance Imaging and 18 F‐Fluorodopa‐Positron Emission Tomography. Movement Disorders. https://doi.org/10.1002/mds.30119

Vancouver

Trujillo P, O'Rourke KR, Roman OC, Song AK, Hett K, Cooper A, et al. Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin‐Sensitive Magnetic Resonance Imaging and 18 F‐Fluorodopa‐Positron Emission Tomography. Movement Disorders. 2025. doi:10.1002/mds.30119

BibTeX
@article{Trujillo2025,
  author = {Trujillo, Paula and O'Rourke, Kaitlyn R and Roman, Olivia C and Song, Alexander K and Hett, Kilian and Cooper, Amy and Black, Bonnie K and Donahue, Manus J and Shibao, Cyndya A and Biaggioni, Italo and Claassen, Daniel O},
  title = {Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin‐Sensitive Magnetic Resonance Imaging and 18 F‐Fluorodopa‐Positron Emission Tomography},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.30119}
}
Kostenlos starten →